PhenoVue anti-MAP2 antibody 100X is a monoclonal unconjugated anti-MAP2 antibody. It specifically recognizes MAP2 (Microtubule-associated protein 2), a neuron-specific protein which promotes the assembly and stability of the microtubule network.
MAP2 is essential for the development and the maintenance of neuronal morphology.
PhenoVue anti-MAP2 antibody is validated for use in imaging and high-content analysis applications.
PhenoVue anti-MAP2 antibody 100X is a monoclonal unconjugated anti-MAP2 antibody. It specifically recognizes MAP2 (Microtubule-associated protein 2), a neuron-specific protein which promotes the assembly and stability of the microtubule network.
MAP2 is essential for the development and the maintenance of neuronal morphology.
PhenoVue anti-MAP2 antibody is validated for use in imaging and high-content analysis applications.
PhenoVue anti-MAP2 antibody is an unconjugated monoclonal mouse anti-MAP2 antibody (IgG1, k) which specifically recognizes human and mouse MAP2 protein. MAP2 is a cytoskeletal component predominantly expressed in neuronal dendrites, and commonly used as a somatodendritic marker.
As such, PhenoVue anti-MAP2 antibody can be used with our PhenoVue neuronal differentiation staining kit.
PhenoVue anti-MAP2 antibody is validated for use in imaging and high-content analysis applications.
Features:
Form |
Solution
|
---|
Application |
High Content Imaging
Microscopy
|
---|---|
Brand |
PhenoVue™
|
Host Species |
Mouse
|
Organelle and Cell Compartment |
Microtubules
|
Quantity |
1 x 100 µL
|
Sample Type |
Fixed samples only
|
Shipping Conditions |
Shipped in Dry Ice
|
Storage Conditions |
-16 °C or below, protected from light
|
Target Species |
Human
Mouse
Rat
|
Type |
Individual Reagent
|
Are you looking for resources, click on the resource type to explore further.
This flyer describes Revvity's PhenoVue cellular imaging reagents.
Are you looking for technical documents related to the product? We have categorized them in dedicated sections below. Explore now.
We are here to answer your questions.